Author:
Liu Huanran,Ubukata Hideyuki,Tabuchi Takanobu,Nakachi Takeshi,Nagata Hiroyuki,Shimazaki Jiro,Motohashi Gyou,Konishi Satoru,Nishimura Motoi,Satani Tetsuro,Hong JianWei,Nakada Ichiro,Saniabadi Abbi R.,Tabuchi Takafumi
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine
Reference42 articles.
1. Bennett MW, O’Connell J, O’Sullivan GC et al (1998) The Fas counterattack in vivo: apoptotic depletion of tumour-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma. J Immunol 160:5669–5675
2. Hahne M, Rimoldi D, Schröter M et al (1996) Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science 274:1363–1366. doi: 10.1126/science.274.5291.1363
3. Niehans GA, Brunner T, Frizelle SP et al (1997) Human lung carcinomas express Fas ligand. Cancer Res 57:1007–1012
4. O’Connell J, Bennett MW, O’Sullivan GC et al (1998) Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer. J Pathol 186:240–246. doi: 10.1002/(SICI)1096-9896(199811)186:3<240::AID-PATH173>3.0.CO;2-L
5. Lee SH, Shin MS, Park WS et al (1999) Immunohistochemical analysis of Fas ligand expression in normal human tissues. APMIS 107:1013–1019
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献